Total Payments
$16,188
2024 Payments
$2,479
Companies
39
Transactions
1,047
Medicare Patients
4,897
Medicare Billing
$440,741
Payment Breakdown by Category
Food & Beverage$16,002 (98.8%)
Education$186.46 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,002 | 1,040 | 98.8% |
| Education | $186.46 | 7 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,564 | 159 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,385 | 97 | $0 (2024) |
| Amgen Inc. | $2,008 | 108 | $0 (2024) |
| ABBVIE INC. | $1,476 | 119 | $0 (2024) |
| Novo Nordisk Inc | $1,362 | 106 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,034 | 70 | $0 (2024) |
| PFIZER INC. | $920.70 | 79 | $0 (2024) |
| Allergan, Inc. | $771.23 | 82 | $0 (2020) |
| GlaxoSmithKline, LLC. | $760.78 | 52 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $420.39 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,479 | 125 | AstraZeneca Pharmaceuticals LP ($529.32) |
| 2023 | $2,379 | 117 | ABBVIE INC. ($483.71) |
| 2022 | $1,601 | 112 | Lilly USA, LLC ($348.34) |
| 2021 | $1,877 | 134 | AstraZeneca Pharmaceuticals LP ($363.63) |
| 2020 | $1,503 | 92 | AstraZeneca Pharmaceuticals LP ($510.94) |
| 2019 | $2,097 | 161 | Amgen Inc. ($447.83) |
| 2018 | $2,031 | 170 | Amgen Inc. ($352.10) |
| 2017 | $2,222 | 136 | Lilly USA, LLC ($581.01) |
All Payment Transactions
1,047 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Obesity | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes Care | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Narcoplepsy | ||||||
| 10/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Obesity | ||||||
| 10/01/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,229 | 2,081 | $319,539 | $109,001 |
| 2022 | 18 | 1,065 | 2,017 | $277,240 | $91,374 |
| 2021 | 23 | 1,409 | 2,698 | $386,316 | $137,058 |
| 2020 | 20 | 1,194 | 2,243 | $313,061 | $103,308 |
Total Patients
4,897
Total Services
9,039
Medicare Billing
$440,741
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 651 | $152,221 | $53,253 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 274 | 470 | $78,751 | $27,740 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $24,880 | $10,833 | 43.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 79 | 91 | $8,554 | $3,538 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,837 | $2,507 | 23.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 31 | 32 | $4,325 | $2,226 | 51.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 37 | $5,025 | $1,601 | 31.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 159 | $9,206 | $1,523 | 16.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 15 | 19 | $5,263 | $1,344 | 25.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 76 | 120 | $7,551 | $1,142 | 15.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 36 | $906.00 | $862.66 | 95.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 43 | 43 | $2,150 | $759.81 | 35.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 16 | 17 | $3,468 | $617.12 | 17.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 23 | $1,148 | $352.00 | 30.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 35 | $3,570 | $337.20 | 9.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 35 | $344.96 | $119.35 | 34.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 22 | 106 | $636.00 | $88.13 | 13.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 14 | 17 | $204.00 | $65.50 | 32.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 65 | $345.00 | $59.60 | 17.3% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 12 | 12 | $156.00 | $30.85 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 605 | $138,932 | $42,199 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 250 | 470 | $74,274 | $24,714 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $18,203 | $8,816 | 48.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 15 | 95 | $8,380 | $3,717 | 44.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $9,092 | $2,580 | 28.4% |
About Dr. Eric Graham, MD
Dr. Eric Graham, MD is a Family Medicine healthcare provider based in Marion, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720120462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Graham, MD has received a total of $16,188 in payments from pharmaceutical and medical device companies, with $2,479 received in 2024. These payments were reported across 1,047 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($16,002).
As a Medicare-enrolled provider, Graham has provided services to 4,897 Medicare beneficiaries, totaling 9,039 services with total Medicare billing of $440,741. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Marion, IL
- Active Since 02/12/2007
- Last Updated 06/01/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720120462
Products in Payments
- TRULICITY (Drug) $1,261
- FARXIGA (Drug) $923.92
- VRAYLAR (Drug) $823.65
- BREZTRI (Drug) $789.50
- TRELEGY ELLIPTA (Drug) $722.35
- ELIQUIS (Drug) $684.13
- Ozempic (Drug) $644.22
- UBRELVY (Drug) $627.70
- MOUNJARO (Drug) $597.01
- Repatha (Biological) $538.14
- Otezla (Drug) $528.08
- JARDIANCE (Drug) $470.38
- Aimovig (Biological) $468.49
- WAKIX (Drug) $420.39
- TRADJENTA (Drug) $400.51
- Prolia (Biological) $355.20
- EMGALITY (Drug) $328.23
- Victoza (Drug) $289.91
- QULIPTA (Drug) $286.67
- SPIRIVA RESPIMAT (Drug) $235.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Marion
Nicole Kennedy, Md, MD
Family Medicine — Payments: $18,979
Family Medicine $18,979
Chelsea Hamman, Md, MD
Family Medicine — Payments: $18,311
Family Medicine $18,311
Emily Bralley, D.o, D.O
Family Medicine — Payments: $18,013
Family Medicine $18,013
Dr. James Mcglothlin, D.o, D.O
Family Medicine — Payments: $17,518
Family Medicine $17,518
Jennifer Jennings, Md, MD
Family Medicine — Payments: $16,264
Family Medicine $16,264
Dr. Jodi Fox, M.d, M.D
Family Medicine — Payments: $11,980
Family Medicine $11,980